25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ALDX (Aldeyra) Stock Analysis
Buy, Hold or Sell?

Let's analyze Aldeyra together

I guess you are interested in Aldeyra The. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Aldeyra’s Financial Insights
  • 📈 Technical Analysis (TA) – Aldeyra’s Price Targets

I'm going to help you getting a better view of Aldeyra The. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aldeyra The

I send you an email if I find something interesting about Aldeyra The.

1. Quick Overview

1.1. Quick analysis of Aldeyra (30 sec.)










1.2. What can you expect buying and holding a share of Aldeyra? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$1.06
Expected worth in 1 year
$0.23
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-0.83
Return On Investment
-20.8%

For what price can you sell your share?

Current Price per Share
$4.00
Expected price per share
$2.08 - $4.67
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aldeyra (5 min.)




Live pricePrice per Share (EOD)
$4.00
Intrinsic Value Per Share
$-7.91 - $-4.50
Total Value Per Share
$-6.85 - $-3.44

2.2. Growth of Aldeyra (5 min.)




Is Aldeyra growing?

Current yearPrevious yearGrowGrow %
How rich?$63.5m$121.5m-$42m-52.9%

How much money is Aldeyra making?

Current yearPrevious yearGrowGrow %
Making money-$14.4m-$7.5m-$6.9m-48.0%
Net Profit Margin-1,616.3%-302.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Aldeyra (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#394 / 884

Most Revenue
#581 / 884

Most Profit
#593 / 884

Most Efficient
#749 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aldeyra?

Welcome investor! Aldeyra's management wants to use your money to grow the business. In return you get a share of Aldeyra.

First you should know what it really means to hold a share of Aldeyra. And how you can make/lose money.

Speculation

The Price per Share of Aldeyra is $4. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aldeyra.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aldeyra, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.06. Based on the TTM, the Book Value Change Per Share is $-0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aldeyra.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.17-4.1%-0.24-6.0%-0.13-3.1%-0.21-5.2%-0.21-5.2%-0.17-4.3%
Usd Book Value Change Per Share-0.12-3.1%-0.21-5.2%-0.10-2.5%-0.18-4.4%0.020.4%0.020.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.12-3.1%-0.21-5.2%-0.10-2.4%-0.18-4.4%0.020.4%0.020.5%
Usd Price Per Share5.75-4.86-5.46-5.63-6.32-6.49-
Price to Earnings Ratio-8.67--5.42--10.83--7.62--8.23--12.29-
Price-to-Total Gains Ratio-46.50--26.32--63.51--40.10--26.26--25.28-
Price to Book Ratio5.42-3.86-2.65-3.04-3.40-7.49-
Price-to-Total Gains Ratio-46.50--26.32--63.51--40.10--26.26--25.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4
Number of shares250
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.210.02
Usd Total Gains Per Share-0.210.02
Gains per Quarter (250 shares)-51.994.42
Gains per Year (250 shares)-207.9517.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-208-2181178
20-416-42623426
30-624-63435044
40-832-84236762
50-1040-105048480
60-1248-1258510198
70-1456-14666118116
80-1664-16747134134
90-1872-18828151152
100-2079-20909168170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%2.048.00.04.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%10.030.00.025.0%14.034.02.028.0%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.049.02.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%10.030.00.025.0%14.034.02.028.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aldeyra The compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.124-0.208+68%-0.099-20%-0.177+43%0.017-836%0.021-695%
Book Value Per Share--1.0621.327-20%2.029-48%1.988-47%2.159-51%1.411-25%
Current Ratio--6.3905.801+10%7.343-13%7.921-19%11.589-45%12.013-47%
Debt To Asset Ratio--0.3180.283+12%0.180+76%0.207+53%0.193+65%0.170+86%
Debt To Equity Ratio--0.4650.400+16%0.220+112%0.269+73%0.248+88%0.218+113%
Dividend Per Share----0%0.004-100%0.001-100%0.001-100%0.000-100%
Enterprise Value--404860637.000346374897.250+17%430791921.000-6%440394479.250-8%496237513.300-18%466742494.525-13%
Eps---0.166-0.241+45%-0.125-24%-0.207+25%-0.209+26%-0.172+4%
Ev To Ebitda Ratio---10.785-6.716-38%-15.904+47%-10.692-1%-11.292+5%-14.576+35%
Free Cash Flow Per Share---0.208-0.191-8%-0.129-38%-0.181-13%-0.173-17%-0.142-32%
Free Cash Flow To Equity Per Share---0.191-0.187-2%-0.134-30%-0.178-7%162362.698-100%81181.368-100%
Gross Profit Margin--1.0001.0010%1.101-9%1.034-3%1.020-2%1.010-1%
Intrinsic Value_10Y_max---4.498----------
Intrinsic Value_10Y_min---7.911----------
Intrinsic Value_1Y_max---0.551----------
Intrinsic Value_1Y_min---0.739----------
Intrinsic Value_3Y_max---1.579----------
Intrinsic Value_3Y_min---2.280----------
Intrinsic Value_5Y_max---2.515----------
Intrinsic Value_5Y_min---3.874----------
Market Cap239582400.000-44%344399700.000291092616.000+18%327179715.000+5%336962663.000+2%378495270.300-9%388699983.150-11%
Net Profit Margin----16.1630%-3.0260%-6.3960%-3.8380%-1.5720%
Operating Margin----15.6820%-2.6990%-6.1270%-3.6760%-1.4940%
Operating Ratio---17.015-100%3.883-100%6.966-100%4.179-100%1.745-100%
Pb Ratio3.767-44%5.4153.859+40%2.651+104%3.040+78%3.402+59%7.487-28%
Pe Ratio-6.032+30%-8.671-5.420-37%-10.828+25%-7.621-12%-8.228-5%-12.285+42%
Price Per Share4.000-44%5.7504.860+18%5.463+5%5.626+2%6.319-9%6.490-11%
Price To Free Cash Flow Ratio-4.803+30%-6.905-6.745-2%19.561-135%1.406-591%-3.966-43%-12.397+80%
Price To Total Gains Ratio-32.348+30%-46.501-26.316-43%-63.510+37%-40.096-14%-26.260-44%-25.277-46%
Quick Ratio--9.1367.518+22%7.578+21%9.882-8%15.415-41%16.813-46%
Return On Assets---0.107-0.130+22%-0.051-52%-0.087-18%-0.087-19%-0.128+20%
Return On Equity---0.156-0.182+17%-0.062-61%-0.113-27%-0.111-29%-0.158+1%
Total Gains Per Share---0.124-0.208+68%-0.095-23%-0.175+42%0.018-800%0.021-683%
Usd Book Value--63598577.00079502372.750-20%121526352.250-48%119049066.583-47%129295301.700-51%84541337.025-25%
Usd Book Value Change Per Share---0.124-0.208+68%-0.099-20%-0.177+43%0.017-836%0.021-695%
Usd Book Value Per Share--1.0621.327-20%2.029-48%1.988-47%2.159-51%1.411-25%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.001-100%0.000-100%
Usd Enterprise Value--404860637.000346374897.250+17%430791921.000-6%440394479.250-8%496237513.300-18%466742494.525-13%
Usd Eps---0.166-0.241+45%-0.125-24%-0.207+25%-0.209+26%-0.172+4%
Usd Free Cash Flow---12469700.000-11426440.000-8%-7713749.250-38%-10812687.167-13%-10366568.600-17%-8491425.700-32%
Usd Free Cash Flow Per Share---0.208-0.191-8%-0.129-38%-0.181-13%-0.173-17%-0.142-32%
Usd Free Cash Flow To Equity Per Share---0.191-0.187-2%-0.134-30%-0.178-7%162362.698-100%81181.368-100%
Usd Market Cap239582400.000-44%344399700.000291092616.000+18%327179715.000+5%336962663.000+2%378495270.300-9%388699983.150-11%
Usd Price Per Share4.000-44%5.7504.860+18%5.463+5%5.626+2%6.319-9%6.490-11%
Usd Profit---9930000.000-14425000.000+45%-7502250.000-24%-12308250.000+24%-12512700.000+26%-10270825.000+3%
Usd Revenue---61131.500-100%98155.000-100%53095.500-100%31857.300-100%603043595028.650-100%
Usd Total Gains Per Share---0.124-0.208+68%-0.095-23%-0.175+42%0.018-800%0.021-683%
 EOD+3 -5MRQTTM+19 -16YOY+8 -293Y+13 -245Y+8 -2910Y+9 -28

3.3 Fundamental Score

Let's check the fundamental score of Aldeyra The based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.032
Price to Book Ratio (EOD)Between0-13.767
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.136
Current Ratio (MRQ)Greater than16.390
Debt to Asset Ratio (MRQ)Less than10.318
Debt to Equity Ratio (MRQ)Less than10.465
Return on Equity (MRQ)Greater than0.15-0.156
Return on Assets (MRQ)Greater than0.05-0.107
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Aldeyra The based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.638
Ma 20Greater thanMa 503.165
Ma 50Greater thanMa 1002.674
Ma 100Greater thanMa 2003.993
OpenGreater thanClose3.980
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Aldeyra The

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-18 22:49:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aldeyra earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aldeyra The:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,616.3%+1,616.3%
TTM-1,616.3%YOY-302.6%-1,313.6%
TTM-1,616.3%5Y-383.8%-1,232.5%
5Y-383.8%10Y-157.2%-226.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM-1,616.3%-141.4%-1,474.9%
YOY-302.6%-186.1%-116.5%
3Y-639.6%-248.3%-391.3%
5Y-383.8%-338.6%-45.2%
10Y-157.2%-488.9%+331.7%
4.3.1.2. Return on Assets

Shows how efficient Aldeyra is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • -10.7% Return on Assets means that Aldeyra generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aldeyra The:

  • The MRQ is -10.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-13.0%+2.3%
TTM-13.0%YOY-5.1%-7.9%
TTM-13.0%5Y-8.7%-4.3%
5Y-8.7%10Y-12.8%+4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.7%-11.5%+0.8%
TTM-13.0%-11.6%-1.4%
YOY-5.1%-11.4%+6.3%
3Y-8.7%-11.8%+3.1%
5Y-8.7%-12.1%+3.4%
10Y-12.8%-13.8%+1.0%
4.3.1.3. Return on Equity

Shows how efficient Aldeyra is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • -15.6% Return on Equity means Aldeyra generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aldeyra The:

  • The MRQ is -15.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.6%TTM-18.2%+2.6%
TTM-18.2%YOY-6.2%-12.0%
TTM-18.2%5Y-11.1%-7.1%
5Y-11.1%10Y-15.8%+4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.6%-13.6%-2.0%
TTM-18.2%-14.9%-3.3%
YOY-6.2%-14.4%+8.2%
3Y-11.3%-17.0%+5.7%
5Y-11.1%-17.9%+6.8%
10Y-15.8%-20.1%+4.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aldeyra The.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aldeyra is operating .

  • Measures how much profit Aldeyra makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aldeyra The:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,568.2%+1,568.2%
TTM-1,568.2%YOY-269.9%-1,298.3%
TTM-1,568.2%5Y-367.6%-1,200.6%
5Y-367.6%10Y-149.4%-218.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-1,568.2%-250.3%-1,317.9%
YOY-269.9%-205.1%-64.8%
3Y-612.7%-220.2%-392.5%
5Y-367.6%-342.6%-25.0%
10Y-149.4%-475.5%+326.1%
4.3.2.2. Operating Ratio

Measures how efficient Aldeyra is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aldeyra The:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM17.015-17.015
TTM17.015YOY3.883+13.132
TTM17.0155Y4.179+12.835
5Y4.17910Y1.745+2.435
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM17.0152.704+14.311
YOY3.8833.063+0.820
3Y6.9663.576+3.390
5Y4.1794.713-0.534
10Y1.7456.512-4.767
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aldeyra The.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aldeyra is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.39 means the company has $6.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aldeyra The:

  • The MRQ is 6.390. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.801. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.390TTM5.801+0.589
TTM5.801YOY7.343-1.542
TTM5.8015Y11.589-5.789
5Y11.58910Y12.013-0.423
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3903.661+2.729
TTM5.8013.786+2.015
YOY7.3434.121+3.222
3Y7.9214.680+3.241
5Y11.5895.765+5.824
10Y12.0136.150+5.863
4.4.3.2. Quick Ratio

Measures if Aldeyra is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Quick Ratio of 9.14 means the company can pay off $9.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aldeyra The:

  • The MRQ is 9.136. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.518. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.136TTM7.518+1.619
TTM7.518YOY7.578-0.061
TTM7.5185Y15.415-7.898
5Y15.41510Y16.813-1.398
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1362.826+6.310
TTM7.5183.128+4.390
YOY7.5783.782+3.796
3Y9.8824.304+5.578
5Y15.4155.703+9.712
10Y16.8136.454+10.359
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aldeyra The.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aldeyra assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aldeyra to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Aldeyra assets are financed with 31.8% credit (debt) and the remaining percentage (100% - 31.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aldeyra The:

  • The MRQ is 0.318. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.283. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.283+0.034
TTM0.283YOY0.180+0.103
TTM0.2835Y0.193+0.091
5Y0.19310Y0.170+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3180.324-0.006
TTM0.2830.347-0.064
YOY0.1800.327-0.147
3Y0.2070.339-0.132
5Y0.1930.349-0.156
10Y0.1700.382-0.212
4.5.4.2. Debt to Equity Ratio

Measures if Aldeyra is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Debt to Equity ratio of 46.5% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aldeyra The:

  • The MRQ is 0.465. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.400. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.400+0.066
TTM0.400YOY0.220+0.180
TTM0.4005Y0.248+0.152
5Y0.24810Y0.218+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4650.383+0.082
TTM0.4000.436-0.036
YOY0.2200.410-0.190
3Y0.2690.446-0.177
5Y0.2480.460-0.212
10Y0.2180.509-0.291
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aldeyra generates.

  • Above 15 is considered overpriced but always compare Aldeyra to the Biotechnology industry mean.
  • A PE ratio of -8.67 means the investor is paying $-8.67 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aldeyra The:

  • The EOD is -6.032. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.671. Based on the earnings, the company is expensive. -2
  • The TTM is -5.420. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.032MRQ-8.671+2.639
MRQ-8.671TTM-5.420-3.251
TTM-5.420YOY-10.828+5.408
TTM-5.4205Y-8.228+2.808
5Y-8.22810Y-12.285+4.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.032-2.197-3.835
MRQ-8.671-2.027-6.644
TTM-5.420-2.527-2.893
YOY-10.828-3.733-7.095
3Y-7.621-3.717-3.904
5Y-8.228-6.036-2.192
10Y-12.285-6.649-5.636
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aldeyra The:

  • The EOD is -4.803. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.905. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.745. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.803MRQ-6.905+2.101
MRQ-6.905TTM-6.745-0.160
TTM-6.745YOY19.561-26.306
TTM-6.7455Y-3.966-2.779
5Y-3.96610Y-12.397+8.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.803-3.007-1.796
MRQ-6.905-2.704-4.201
TTM-6.745-3.627-3.118
YOY19.561-4.334+23.895
3Y1.406-5.070+6.476
5Y-3.966-8.532+4.566
10Y-12.397-9.305-3.092
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aldeyra is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.42 means the investor is paying $5.42 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aldeyra The:

  • The EOD is 3.767. Based on the equity, the company is fair priced.
  • The MRQ is 5.415. Based on the equity, the company is overpriced. -1
  • The TTM is 3.859. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.767MRQ5.415-1.648
MRQ5.415TTM3.859+1.556
TTM3.859YOY2.651+1.208
TTM3.8595Y3.402+0.457
5Y3.40210Y7.487-4.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.7671.921+1.846
MRQ5.4151.843+3.572
TTM3.8592.113+1.746
YOY2.6512.467+0.184
3Y3.0402.541+0.499
5Y3.4023.666-0.264
10Y7.4874.311+3.176
4.6.2. Total Gains per Share

2.4. Latest News of Aldeyra The

Does Aldeyra The still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Aldeyra The to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-17
13:14
Aldeyra resubmits NDA for dry eye disease drug after trial successRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aldeyra The.

4.8.1. Institutions holding Aldeyra The

Institutions are holding 56.166% of the shares of Aldeyra The.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Perceptive Advisors LLC15.48671.8792927585100
2025-03-31Knoll Capital Management LP9.141820.4806547551600
2025-03-31BlackRock Inc6.23760.00053736038-54152-1.4287
2025-03-31Vanguard Group Inc6.20750.00043718018-38770-1.032
2025-03-31Ardsley Advisory Partners2.92181.8928175000060000052.1739
2025-03-31Kennedy Capital Management Inc2.05930.16941233414-235105-16.0097
2025-03-31Geode Capital Management, LLC1.89970.00051137828182731.6322
2025-03-31State Street Corp1.70530.00021021381-11992-1.1605
2025-03-31Kingdon Capital Management LLC1.30060.4747790007790000
2025-03-31Dimensional Fund Advisors, Inc.1.11840.001669850-65913-8.9585
2025-03-31Morgan Stanley - Brokerage Accounts0.92670.0002555059-24656-4.2531
2025-03-31Federated Hermes Inc0.92010.00685510917140.1297
2025-03-31Amvescap Plc.0.83670.00065011374712311575.7072
2025-03-31683 Capital Management LLC0.79470.188847600018600064.1379
2025-03-31Bank of America Corp0.68210.000240854210229633.4032
2024-12-31Wells Fargo & Co0.65720.000439365473481.9021
2025-03-31AQR Capital Management LLC0.65540.0023392555321992456.3185
2025-03-31Northern Trust Corp0.65040.0003389582-15935-3.9296
2025-03-31Nuveen, LLC0.58190.0033485213485210
2025-03-31Deutsche Bank AG0.5250.0007314423-4864-1.5234
Total 55.308925.101933127460+2383988+7.2%

4.9.2. Funds holding Aldeyra The

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.97420.0003178141400
2025-05-31iShares Russell 2000 ETF2.2430.0047134348000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.16980.0018700665-1103-0.1572
2025-03-31Vanguard Explorer Inv0.98980.0172592856-87148-12.8158
2025-03-31Fidelity Small Cap Index0.83250.0119498623-1839-0.3675
2025-03-31Kennedy Micro Cap0.77610.5634464857-57920-11.0793
2025-05-31iShares Russell 2000 Value ETF0.68810.008341216400
2025-05-30Invesco Dorsey Wright SmallCap Momt ETF0.68470.136841008700
2025-03-31Federated Hermes MDT SCG Institutional0.53450.412332014500
2025-03-31Federated Hermes MDT Small Cap Growth IS0.53450.411932014500
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.47680.001528559300
2025-04-30DWS ESG Biotech LC0.44590.2197267077-5-0.0019
2024-12-31Kennedy Extended Small Cap0.43990.124263493-29228-9.9849
2025-03-31Kennedy Small Cap Select0.41720.5698249910128215.4077
2025-04-30Vanguard Russell 2000 ETF0.41240.0055247021138185.9253
2025-04-30Fidelity Extended Market Index0.39840.0018238633-2281-0.9468
2025-03-31Federated Hermes MDT SCC Institutional0.38040.102922781400
2025-03-31Federated Hermes MDT Small Cap Core IS0.38040.102922781400
2025-03-31Carillon Eagle Small Cap Growth A0.35530.3098212824-9408-4.2334
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.30920.004618520000
Total 15.44313.01119249815-162293-1.8%

5.3. Insider Transactions

Insiders are holding 3.132% of the shares of Aldeyra The.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-04-03Perceptive Advisors LlcSELL34000001.42
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets93,196
Total Liabilities29,597
Total Stockholder Equity63,599
 As reported
Total Liabilities 29,597
Total Stockholder Equity+ 63,599
Total Assets = 93,196

Assets

Total Assets93,196
Total Current Assets91,287
Long-term Assets1,909
Total Current Assets
Cash And Cash Equivalents 50,351
Short-term Investments 39,707
Net Receivables 756
Other Current Assets 473
Total Current Assets  (as reported)91,287
Total Current Assets  (calculated)91,287
+/-0
Long-term Assets
Property Plant Equipment 467
Long-term Assets Other 1,442
Long-term Assets  (as reported)1,909
Long-term Assets  (calculated)1,909
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities14,286
Long-term Liabilities15,311
Total Stockholder Equity63,599
Total Current Liabilities
Short-term Debt 255
Accounts payable 346
Other Current Liabilities 7,684
Total Current Liabilities  (as reported)14,286
Total Current Liabilities  (calculated)8,286
+/- 6,000
Long-term Liabilities
Long term Debt 15,099
Capital Lease Obligations Min Short Term Debt213
Long-term Liabilities  (as reported)15,311
Long-term Liabilities  (calculated)15,311
+/- 0
Total Stockholder Equity
Common Stock60
Retained Earnings -460,040
Accumulated Other Comprehensive Income 2
Other Stockholders Equity 523,577
Total Stockholder Equity (as reported)63,599
Total Stockholder Equity (calculated)63,599
+/-0
Other
Capital Stock60
Cash and Short Term Investments 90,058
Common Stock Shares Outstanding 59,887
Current Deferred Revenue6,000
Liabilities and Stockholders Equity 93,196
Net Debt -34,784
Net Invested Capital 78,697
Net Working Capital 78,443
Property Plant and Equipment Gross 467
Short Long Term Debt Total 15,567



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
1,977
0
0
2,819
3,743
2,891
11,805
10,351
8,787
15,931
33,878
31,350
28,205
23,437
32,884
29,191
25,188
31,532
26,468
49,229
44,175
40,776
43,286
37,132
95,091
88,128
73,839
77,441
75,518
63,029
71,627
88,324
83,353
147,306
256,427
247,218
233,137
222,693
201,015
189,692
181,292
168,219
155,616
147,282
148,327
141,302
126,044
117,319
104,607
93,196
93,196104,607117,319126,044141,302148,327147,282155,616168,219181,292189,692201,015222,693233,137247,218256,427147,30683,35388,32471,62763,02975,51877,44173,83988,12895,09137,13243,28640,77644,17549,22926,46831,53225,18829,19132,88423,43728,20531,35033,87815,9318,78710,35111,8052,8913,7432,819001,977
   > Total Current Assets 
1,977
1
0
2,769
3,271
2,155
11,805
10,345
8,760
15,898
33,837
31,226
28,088
23,309
32,809
29,126
25,131
31,473
26,342
49,053
43,966
40,605
43,071
36,845
94,769
86,996
72,856
77,020
75,169
62,752
71,423
88,193
83,059
147,073
256,261
246,772
232,753
222,355
200,741
189,483
181,023
168,017
155,479
147,210
143,347
133,527
121,790
116,721
104,072
91,287
91,287104,072116,721121,790133,527143,347147,210155,479168,017181,023189,483200,741222,355232,753246,772256,261147,07383,05988,19371,42362,75275,16977,02072,85686,99694,76936,84543,07140,60543,96649,05326,34231,47325,13129,12632,80923,30928,08831,22633,83715,8988,76010,34511,8052,1553,2712,769011,977
       Cash And Cash Equivalents 
1,224
-1
0
2,764
3,262
2,146
11,536
10,142
8,527
15,721
33,570
30,618
14,649
10,149
17,608
14,569
12,015
19,303
14,610
33,104
20,023
20,964
24,606
18,009
47,357
44,298
39,400
51,604
44,426
38,543
60,689
86,176
77,858
138,442
249,739
241,369
229,791
158,909
121,012
128,651
144,419
165,028
151,676
143,335
142,823
52,492
31,030
28,120
54,527
50,351
50,35154,52728,12031,03052,492142,823143,335151,676165,028144,419128,651121,012158,909229,791241,369249,739138,44277,85886,17660,68938,54344,42651,60439,40044,29847,35718,00924,60620,96420,02333,10414,61019,30312,01514,56917,60810,14914,64930,61833,57015,7218,52710,14211,5362,1463,2622,7640-11,224
       Short-term Investments 
0
2
0
0
0
0
0
0
0
0
0
0
12,942
12,877
14,941
14,307
12,898
11,910
11,211
14,807
22,923
17,975
17,073
17,134
46,242
37,827
30,057
24,567
28,939
22,834
5,501
0
0
0
0
0
0
57,957
75,677
56,679
29,882
29,882
0
0
0
30,545
49,302
44,624
46,624
39,707
39,70746,62444,62449,30230,54500029,88229,88256,67975,67757,9570000005,50122,83428,93924,56730,05737,82746,24217,13417,07317,97522,92314,80711,21111,91012,89814,30714,94112,87712,942000000000020
       Net Receivables 
750
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,000
0
17,000
11,000
44,000
39,000
32,000
26,000
28,000
23,000
10,000
15,000
25,000
50,000
125,000
125,000
125,000
65,000
79,000
21,500
3,242
24
0
0
0
50,000
40,000
0
0
756
7560040,00050,000000243,24221,50079,00065,000125,000125,000125,00050,00025,00015,00010,00023,00028,00026,00032,00039,00044,00011,00017,000018,0000000000000000000000750
       Other Current Assets 
3
0
0
4
8
19
539
405
465
354
534
1,215
995
567
520
500
437
521
1,043
2,283
1,019
3,334
1,393
1,703
1,170
48,744
38,798
27,698
1,804
25,750
5,233
19,035
5,201
58,846
6,522
5,403
2,933
5,489
4,052
4,154
6,722
2,965
3,804
3,875
524
490
46,354
43,976
709
473
47370943,97646,3544905243,8753,8042,9656,7224,1544,0525,4892,9335,4036,52258,8465,20119,0355,23325,7501,80427,69838,79848,7441,1701,7031,3933,3341,0192,2831,0435214375005205679951,2155343544654055391984003
   > Long-term Assets 
0
-1
0
50
472
735
0
6
27
33
41
125
117
127
75
66
56
58
126
177
209
171
215
286
322
1,132
983
421
349
277
205
132
293
233
166
446
384
338
274
209
269
202
137
72
4,980
7,774
4,254
599
2,746
1,909
1,9092,7465994,2547,7744,980721372022692092743383844461662332931322052773494219831,1323222862151712091771265856667512711712541332760735472500-10
       Property Plant Equipment 
0
0
0
0
0
0
0
6
13
13
41
88
80
81
75
66
56
58
48
38
43
171
215
243
235
594
491
421
349
277
205
132
293
233
166
446
384
338
274
209
269
202
137
72
517
456
394
331
267
467
467267331394456517721372022692092743383844461662332931322052773494214915942352432151714338485856667581808841131360000000
       Other Assets 
0
0
0
0
472
736
0
0
14
20
0
36
36
46
0
0
0
0
78
138
166
0
0
43
87
538
492
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000049253887430016613878000046363602014007364720000
> Total Liabilities 
27,132
0
0
14,583
2,128
4,027
1,990
2,087
2,503
2,105
2,353
2,655
3,326
2,910
3,366
3,520
3,538
3,537
3,128
3,324
4,574
4,775
6,305
8,537
8,473
9,648
6,506
26,562
27,436
19,557
18,838
19,154
23,844
21,232
22,747
27,548
27,402
32,004
26,986
27,498
30,284
30,976
25,733
24,275
28,532
27,882
27,733
32,224
33,602
29,597
29,59733,60232,22427,73327,88228,53224,27525,73330,97630,28427,49826,98632,00427,40227,54822,74721,23223,84419,15418,83819,55727,43626,5626,5069,6488,4738,5376,3054,7754,5743,3243,1283,5373,5383,5203,3662,9103,3262,6552,3532,1052,5032,0871,9904,0272,12814,5830027,132
   > Total Current Liabilities 
363
0
0
201
605
692
1,175
846
1,328
1,036
1,391
1,374
2,115
1,808
2,373
2,637
2,299
2,409
2,112
2,419
3,354
3,667
5,310
7,654
8,473
9,492
6,390
12,116
12,908
4,887
4,920
6,461
12,409
11,091
7,409
11,942
11,773
16,354
16,243
24,195
15,361
16,008
15,605
21,617
22,260
21,676
27,595
17,153
18,602
14,286
14,28618,60217,15327,59521,67622,26021,61715,60516,00815,36124,19516,24316,35411,77311,9427,40911,09112,4096,4614,9204,88712,90812,1166,3909,4928,4737,6545,3103,6673,3542,4192,1122,4092,2992,6372,3731,8082,1151,3741,3911,0361,3288461,17569260520100363
       Short-term Debt 
167
0
0
0
143
388
407
0
78
194
310
0
78
194
310
427
78
194
310
427
116
233
349
465
0
442
423
438
226
344
1,010
2,318
3,893
5,271
237
444
230
472
5,411
12,818
1,161
1,145
6,154
13,592
15,625
15,452
15,752
543
303
255
25530354315,75215,45215,62513,5926,1541,1451,16112,8185,4114722304442375,2713,8932,3181,010344226438423442046534923311642731019478427310194780310194780407388143000167
       Short Long Term Debt 
0
0
0
0
0
0
0
0
78
0
0
0
78
0
0
0
78
194
1,327
427
116
233
349
465
0
221
0
0
0
0
894
2,259
3,660
5,095
0
0
0
0
4,926
12,449
912
954
5,894
13,461
15,147
15,205
15,242
280
31
0
03128015,24215,20515,14713,4615,89495491212,4494,92600005,0953,6602,259894000022104653492331164271,32719478000780007800000000
       Accounts payable 
73
0
0
65
342
166
556
482
341
406
629
744
851
578
823
734
275
695
763
485
1,001
1,619
802
3,442
3,052
4,013
2,774
572
808
1,073
217
124
382
449
1,094
468
1,020
2,443
264
1,307
134
430
271
247
1,338
280
254
187
180
346
3461801872542801,3382472714301341,3072642,4431,0204681,0944493821242171,0738085722,7744,0133,0523,4428021,6191,001485763695275734823578851744629406341482556166342650073
       Other Current Liabilities 
115
0
0
107
104
138
211
364
909
436
452
630
1,186
1,036
1,235
1,477
1,946
1,520
1,039
1,507
2,236
1,815
4,159
3,746
5,421
5,036
3,192
11,106
11,873
3,469
3,694
4,019
8,135
5,372
6,078
11,030
10,523
13,440
10,568
10,070
14,066
14,434
9,180
7,778
5,297
5,944
5,588
10,423
8,666
7,684
7,6848,66610,4235,5885,9445,2977,7789,18014,43414,06610,07010,56813,44010,52311,0306,0785,3728,1354,0193,6943,46911,87311,1063,1925,0365,4213,7464,1591,8152,2361,5071,0391,5201,9461,4771,2351,0361,18663045243690936421113810410700115
   > Long-term Liabilities 
26,768
0
0
14,382
1,523
3,336
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
157
116
14,445
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,606
15,629
15,650
10,744
3,303
14,923
14,968
10,128
2,657
6,272
6,206
139
15,070
15,000
15,311
15,31115,00015,0701396,2066,2722,65710,12814,96814,9233,30310,74415,65015,62915,60615,33810,14111,43412,69313,91714,67014,52814,44511615708839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,2418163,3361,52314,3820026,768
       Long term Debt Total 
0
0
0
0
0
972
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
0
0
14,387
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,421
15,504
15,587
10,744
3,303
14,923
14,968
0
0
0
0
0
0
0
0
0000000014,96814,9233,30310,74415,58715,50415,42115,33810,14111,43412,69313,91714,67014,52814,3870008839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,24181697200000
       Long term Debt 
2,535
0
0
0
4,648
972
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
157
0
14,387
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,421
15,504
15,587
10,744
3,303
14,923
14,968
10,128
2,657
0
0
0
15,000
15,000
15,099
15,09915,00015,0000002,65710,12814,96814,9233,30310,74415,58715,50415,42115,33810,14111,43412,69313,91714,67014,52814,387015708839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,2418169724,6480002,535
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
378
328
278
226
172
116
59
233
176
118
407
355
299
243
185
249
190
130
66
511
453
394
333
272
468
46827233339445351166130190249185243299355407118176233591161722262783283780000000000000000000000000
       Warrants
0
0
0
0
0
77,018
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000077,01800000
       Other Liabilities 
24,234
0
0
0
394
604
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000060439400024,234
       Long-term Liabilities Other 
0
0
0
0
0
2,231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
157
116
59
0
0
0
0
0
0
0
185
125
63
0
0
0
0
0
0
0
0
0
0
0
0
0000000000006312518500000005911615700000000000000000002,23100000
       Deferred Long Term Liability 
0
0
0
0
0
132
0
0
14
0
0
0
36
0
0
0
0
0
0
0
166
0
0
43
87
538
492
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000492538874300166000000036000140013200000
> Total Stockholder Equity
-25,155
1
0
-11,764
-1,904
-1,137
9,815
8,264
6,284
13,827
31,525
28,695
24,878
20,527
29,518
25,672
21,650
27,995
23,340
45,905
39,601
36,001
36,981
28,595
86,618
78,480
67,333
50,879
48,082
43,473
52,790
69,170
59,509
126,074
233,680
219,670
205,736
190,689
174,029
162,194
151,008
137,243
129,883
123,008
119,795
113,419
98,310
85,096
71,005
63,599
63,59971,00585,09698,310113,419119,795123,008129,883137,243151,008162,194174,029190,689205,736219,670233,680126,07459,50969,17052,79043,47348,08250,87967,33378,48086,61828,59536,98136,00139,60145,90523,34027,99521,65025,67229,51820,52724,87828,69531,52513,8276,2848,2649,815-1,137-1,904-11,76401-25,155
   Common Stock
0
0
0
4
0
0
6
6
6
7
10
10
10
10
12
13
13
15
15
19
19
20
21
21
26
27
27
27
29
30
33
39
39
48
58
58
58
58
58
59
59
59
59
59
59
59
59
60
60
60
606060595959595959595958585858584839393330292727272621212019191515131312101010107666004000
   Retained Earnings Total Equity
0
0
0
0
0
40,923
-42,058
-44,067
-46,512
-48,648
-50,880
-54,246
-58,602
-63,569
-67,872
-72,650
-77,301
-82,392
-87,701
-92,687
-99,642
-108,039
-117,089
-127,902
-138,535
-154,159
-167,486
-186,201
-199,362
-209,230
-216,750
-225,624
-236,916
-248,206
-263,143
-278,937
-294,692
-311,480
-329,261
-343,814
-356,717
-372,332
0
0
0
0
0
0
0
0
00000000-372,332-356,717-343,814-329,261-311,480-294,692-278,937-263,143-248,206-236,916-225,624-216,750-209,230-199,362-186,201-167,486-154,159-138,535-127,902-117,089-108,039-99,642-92,687-87,701-82,392-77,301-72,650-67,872-63,569-58,602-54,246-50,880-48,648-46,512-44,067-42,05840,92300000
   Accumulated Other Comprehensive Income 
0
-54
0
0
0
0
-11,805
-10,351
0
0
0
0
-8
2
5
7
0
-5
-5
-1
-18
-16
-3
-5
-9
7
13
6
6
58
5
0
0
0
0
0
0
-62
-286
-286
-104
-104
0
0
0
-3
-10
67
37
2
23767-10-3000-104-104-286-286-6200000055866137-9-5-3-16-18-1-5-50752-80000-10,351-11,8050000-540
   Capital Surplus 
0
0
0
0
0
1,277
51,867
52,325
52,790
62,468
82,395
82,932
83,479
84,085
97,372
98,302
98,938
110,377
111,031
138,574
139,242
144,037
154,052
156,481
225,136
232,605
234,779
237,048
247,410
252,616
269,502
294,755
296,386
374,232
496,764
498,549
500,369
502,172
503,518
506,235
507,770
509,517
0
0
0
0
0
0
0
0
00000000509,517507,770506,235503,518502,172500,369498,549496,764374,232296,386294,755269,502252,616247,410237,048234,779232,605225,136156,481154,052144,037139,242138,574111,031110,37798,93898,30297,37284,08583,47982,93282,39562,46852,79052,32551,8671,27700000
   Treasury Stock00000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
897
1,103
1,277
51,867
52,325
52,790
62,468
82,395
82,932
83,479
84,085
97,372
98,302
98,938
110,377
111,031
138,574
139,242
144,037
154,052
156,481
225,136
232,605
234,779
237,048
247,410
252,616
269,502
294,755
296,386
374,232
496,764
498,549
500,369
502,172
503,518
506,235
507,770
509,517
511,144
512,455
513,995
515,704
517,449
519,271
521,018
523,577
523,577521,018519,271517,449515,704513,995512,455511,144509,517507,770506,235503,518502,172500,369498,549496,764374,232296,386294,755269,502252,616247,410237,048234,779232,605225,136156,481154,052144,037139,242138,574111,031110,37798,93898,30297,37284,08583,47982,93282,39562,46852,79052,32551,8671,2771,103897000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-250
Gross Profit-250-250
 
Operating Income (+$)
Gross Profit-250
Operating Expense-60,117
Operating Income-60,117-60,367
 
Operating Expense (+$)
Research Development48,225
Selling General Administrative11,892
Selling And Marketing Expenses0
Operating Expense60,11760,117
 
Net Interest Income (+$)
Interest Income6,192
Interest Expense-1,926
Other Finance Cost-0
Net Interest Income4,266
 
Pretax Income (+$)
Operating Income-60,117
Net Interest Income4,266
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-55,851-64,383
EBIT - interestExpense = -62,293
-55,851,499,851
-53,925
Interest Expense1,926
Earnings Before Interest and Taxes (EBIT)-60,367-53,925
Earnings Before Interest and Taxes (EBITDA)-60,117
 
After tax Income (+$)
Income Before Tax-55,851
Tax Provision-0
Net Income From Continuing Ops-55,851-55,851
Net Income-55,851
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net4,266-4,266
 

Technical Analysis of Aldeyra
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aldeyra. The general trend of Aldeyra is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aldeyra's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Aldeyra Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aldeyra The.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.09 < 4.66 < 4.67.

The bearish price targets are: 2.6 > 2.42 > 2.08.

Know someone who trades $ALDX? Share this with them.👇

Aldeyra The Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aldeyra The. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aldeyra The Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aldeyra The. The current macd is 0.35933231.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aldeyra price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aldeyra. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aldeyra price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Aldeyra The Daily Moving Average Convergence/Divergence (MACD) ChartAldeyra The Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aldeyra The. The current adx is 33.50.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aldeyra shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Aldeyra The Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aldeyra The. The current sar is 3.588792.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Aldeyra The Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aldeyra The. The current rsi is 76.64. The current phase is Overbought in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bear market: Short-term excessive buying, potential for relief decline. Consider shorting, be cautious of potential pullback. -1
  • Trending up: The RSI is trending up. +1
Aldeyra The Daily Relative Strength Index (RSI) ChartAldeyra The Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aldeyra The. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aldeyra price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aldeyra The Daily Stochastic Oscillator ChartAldeyra The Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aldeyra The. The current cci is 147.87.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Aldeyra The Daily Commodity Channel Index (CCI) ChartAldeyra The Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aldeyra The. The current cmo is 66.13.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Aldeyra The Daily Chande Momentum Oscillator (CMO) ChartAldeyra The Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aldeyra The. The current willr is -13.04347826.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Aldeyra The Daily Williams %R ChartAldeyra The Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aldeyra The.

Aldeyra The Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aldeyra The. The current atr is 0.26660476.

Aldeyra The Daily Average True Range (ATR) ChartAldeyra The Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aldeyra The. The current obv is 55,854,874.

Aldeyra The Daily On-Balance Volume (OBV) ChartAldeyra The Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aldeyra The. The current mfi is 76.60.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aldeyra The Daily Money Flow Index (MFI) ChartAldeyra The Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aldeyra The.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Aldeyra The Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aldeyra The based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.638
Ma 20Greater thanMa 503.165
Ma 50Greater thanMa 1002.674
Ma 100Greater thanMa 2003.993
OpenGreater thanClose3.980
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Aldeyra with someone you think should read this too:
  • Are you bullish or bearish on Aldeyra? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aldeyra? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aldeyra The

I send you an email if I find something interesting about Aldeyra The.


Comments

How you think about this?

Leave a comment

Stay informed about Aldeyra The.

Receive notifications about Aldeyra The in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.